Defilade Capital Management »

Tyra Biosciences shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Tyra Biosciences (TYRA) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Tyra Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Tyra Biosciences held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tyra Biosciences by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 377k 31.94

More positions owned by Defilade Capital Management

Eli Lilly & Co. (LLY)
Pfizer (PFE)
Veeva Sys Cl A Com (VEEV)
BioMarin Pharmaceutical (BMRN)
Ptc Therapeutics I (PTCT)
Baxter International (BAX)
Insmed Com Par $.01 (INSM)
Zimmer Holdings (ZBH)
Insulet Corporation (PODD)
Thermo Fisher Scientific (TMO)
Abbott Laboratories (ABT)
Ascendis Pharma A/s Ord Shs (ASND)
Solventum Corp Com Shs (SOLV)
Medtronic SHS (MDT)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Tyra Biosciences

RA Capital Management
FMR
Jupiter Topco
Henderson Group
Alta Partners Management Company
Nextech Invest
TCG Crossover Management
BlackRock
Commodore Capital
Paradigm Biocapital Advisors
Vanguard Capital Management
BVF
State Street Corporation
5AM Venture Management
Deerfield Management Company

View all funds holding Tyra Biosciences